Anthem Biosciences Ltd
Anthem Biosciences Ltd (ANTHEM) last traded at ₹874, a market capitalisation of ₹49,200 crore, on a P/E of 83.0. Over the past 52 weeks the stock has ranged between ₹579 and ₹904. Anthem Biosciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹418 crore and net profit of ₹120 crore. Figures are as of 25 Aug 2026 and are not real time.
Anthem Biosciences Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Anthem Biosciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹418 cr, down 22.6% from ₹540 cr a year earlier. Net profit was ₹120 cr, down 11.8% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 525 | 498 | 483 | 540 | 550 | 423 | 611 | 418 |
| Expenses | 330 | 338 | 288 | 349 | 332 | 266 | 344 | 268 |
| Operating profit | 195 | 160 | 195 | 191 | 218 | 157 | 267 | 151 |
| OPM % | 37% | 32% | 40% | 35% | 40% | 37% | 44% | 36% |
| Other income | 28 | 24 | 14 | 23 | 48 | 8 | 52 | 25 |
| Interest | 4 | 3 | 1 | 2 | 3 | 0 | 2 | 1 |
| Depreciation | 20 | 20 | 30 | 26 | 34 | 35 | 40 | 30 |
| Profit before tax | 200 | 161 | 178 | 186 | 230 | 130 | 278 | 145 |
| Tax % | 19% | 23% | 54% | 27% | 24% | 29% | 32% | 17% |
| Net profit | 162 | 124 | 83 | 136 | 173 | 93 | 190 | 120 |
| EPS (₹) | 2.90 | 2.22 | 1.48 | 2.42 | 3.09 | 1.65 | 3.38 | 2.13 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Anthem Biosciences Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1,103 | 1,231 | 1,057 | 1,419 | 1,845 | 2,124 | 2,002 |
| Operating profit | 408 | 565 | 431 | 506 | 672 | 834 | 793 |
| OPM % | 37% | 46% | 41% | 36% | 36% | 39% | 40% |
| Net profit | 271 | 406 | 385 | 367 | 451 | 592 | 576 |
| EPS (₹) | 319.74 | 462.09 | 6.75 | 6.57 | 8.07 | 10.54 | 10.25 |
TTM is the trailing twelve months to the most recent quarter.
Anthem Biosciences Ltd growth and returns
- 10 Years
- %
- 5 Years
- 14%
- 3 Years
- 26%
- TTM
- -2%
- 10 Years
- %
- 5 Years
- 17%
- 3 Years
- 21%
- TTM
- 18%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 5%
- 10 Years
- %
- 5 Years
- 23%
- 3 Years
- 21%
- Last Year
- 22%
Anthem Biosciences Ltd shareholding pattern
Promoters held 71.42% at Jun 2026, down from 74.69% at Sep 2025. FIIs 2.57% and DIIs 13.48%.
| % held | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Promoters | 74.69% | 74.69% | 74.67% | 71.42% |
| FIIs | 1.66% | 1.37% | 1.28% | 2.57% |
| DIIs | 7.21% | 7.60% | 11.55% | 13.48% |
| Public | 16.42% | 16.34% | 12.48% | 12.52% |
| No. of shareholders | 2,17,681 | 1,99,492 | 1,80,220 | 1,73,273 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Track Anthem Biosciences Ltd
Cruxal reads every Anthem Biosciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.